AxoGen Inc
NASDAQ:AXGN
AxoGen Inc
NASDAQ:AXGN
Price:
32.75
USD
-0.27%
Market Cap:
$1.7B
Relative Value
The Relative Value of one
AXGN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 32.75 USD,
AxoGen Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AXGN Relative Value
HIDDEN
Multiples Across Competitors
AXGN Competitors Multiples
AxoGen Inc Competitors
AxoGen Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
AxoGen Inc
NASDAQ:AXGN
|
1.5B USD | 6.9 | -98.4 | -1 839.4 | -204.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
189.7B USD | 4.3 | 29 | 16.6 | 22.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
169.7B USD | 17 | 59.8 | 45.3 | 55.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
132.6B USD | 5.3 | 40.9 | 20.8 | 25.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.5B USD | 3.2 | 24.4 | 13.5 | 19.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
104.6B USD | 5.3 | 36.5 | 21.4 | 28.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.6B EUR | 1.8 | 20.3 | 11.3 | 16 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.4B USD | 8 | 45.3 | 24.9 | 27.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.2B USD | 10.8 | 43.8 | 31 | 34.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.7B USD | 2.1 | 25.7 | 10.1 | 17.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.5B USD | 6.2 | 22.7 | 16 | 17.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
